Ferroptosis

Related Products

Ferroptosis is a non-apoptotic form of regulated cell death. It is distinct from other regulated cell death phenotypes, such as apoptosis and necroptosis. Ferroptosis is characterized by extensive lipid peroxidation, which can be suppressed by iron chelators or lipophilic antioxidants. Mechanistically, Ferroptosis inducers are divided into two classes: (1) inhibitors of cystine import via system x_c⁻ (e.g., Erastin), which subsequently causes depletion of glutathione (GSH), and (2) covalent inhibitors (e.g., (1S, 3R)-RSL3) of glutathione peroxidase 4 (GPX4). Since GPX4 reduces lipid hydroperoxides using GSH as a co-substrate, both compound classes ultimately result in loss of GPX4 activity, followed by elevated levels of lipid reactive oxygen species (ROS) and consequent cell death.

Ferroptosis is an iron- and ROS-dependent form of regulated cell death (RCD). Misregulated Ferroptosis has been implicated in multiple physiological and pathological processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity.

Ferroptosis Related Products (496)
Antibodies (6)
Related Compound Screening Libraries (1)
Ferroptosis Signaling Pathway

By Effects:	Controls (4) Inhibitors (219) Activators (130) Inducers (106)

Cat. No.	Product Name	Effect	Purity	Chemical Structure

HY-106376B

DL-Buthionine-(S,R)-sulfoximine hydrochloride	Activator	99.09%
DL-Buthionine-(S,R)-sulfoximine hydrochloride (Buthionine sulfoximine hydrochloride) is a potent inhibitor of glutamylcysteine synthetase biosynthesis.

HY-16702A

Pifithrin-β hydrobromide	Activator	99.97%
Pifithrin-β hydrobromide (PFT β hydrobromide) is a potent p53 inhibitor with an IC₅₀ of 23 μM.

HY-112909

UAMC-3203	Inhibitor	99.92%
UAMC-3203 is a potent and selective Ferroptosis inhibitor with an IC₅₀ of 12 nM.

HY-50898A

Lapatinib ditosylate	Activator	99.98%
Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC₅₀ values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively.

HY-44307

84-B10	Inhibitor	99.61%
84-B10 is a 3-phenylglutaric acid derivative. 84-B10 inhibits cisplatin (HY-17394) induced tubular ferroptosis. 84-B10 attenuates cisplatin-induced mitochondrial damage and oxidative stress. 84-B10 ameliorates cisplatin-induced acute kidney injury (AKI).

HY-162065

N6F11	Inducer	98.37%
N6F11 is a selective ferroptosis inducer, and can selectively induce ferroptosis by targeting TRIM25-mediated GPX4 degradation in cancer cells while sparing immune cells. N6F11 initiates HMGB1-dependent antitumor immunity mediated by CD8⁺ T cells.

HY-18973

Dp44mT	Inhibitor	≥98.0%
Dp44mT is an iron chelator with selective anticancer activity.

HY-A0023

Alogliptin Benzoate	Inhibitor	99.99%
Alogliptin Benzoate (SYR-322) is a potent, selective and orally active inhibitor of DPP-4 with an IC₅₀ of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Alogliptin Benzoate can be used for the research of type 2 diabetes.

HY-B1066

Butylhydroxyanisole		99.78%
Butylhydroxyanisole (Butylated hydroxyanisole) is an antioxidant used as a food additive preservative. Butylhydroxyanisole mediates liver toxicity, retardation in reproductive organ development and learning, and sleep deficit. Butylhydroxyanisole exerts neurotoxic effects and leads to disruption of the brain and nerve development. Butylhydroxyanisole is a ferroptosis inducer.

HY-F0003A

NADPH tetracyclohexanamine	Inhibitor	99.86%
NADPH tetracyclohexanamine is a ubiquitous cofactor and biological reducing agent.

HY-19980A

PRIMA-1	Activator	≥98.0%
PRIMA-1 (NSC-281668) is a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.

HY-17386A

Rosiglitazone hydrochloride	Inhibitor	99.81%
Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC₅₀: 60 nM, K_d: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC₅₀: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer.

HY-A0023A

Alogliptin	Inhibitor	99.85%
Alogliptin (SYR-322 free base) is a potent, selective and orally active inhibitor of DPP-4 with an IC₅₀ of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Alogliptin can be used for the research of type 2 diabetes.

HY-163002

viFSP1		99.45%
viFSP1 is a species-independent FSP1 inhibitor. viFSP1 directly inhibits FSP1 by targeting the highly conserved NAD(P)H binding pocket of FSP1. viFSP1 can induce Ferroptosis in FSP1-dependent cells. viFSP1 can be used in renal and breast cancer research.

HY-N4118

Cephaeline	Inducer	99.77%
Cephaeline ((-)-Cephaeline), a desmethyl analog of Emetine, is a phenolic alkaloid in Indian Ipecac roots isolated from the Cephaelis ipecacuanha. Cephaeline exhibits potent inhibition of both Zika virus (ZIKV) and Ebola virus (EBOV) infections. Cephaeline is an inductor of histone H3 acetylation and an inhibitor of mucoepidermoid carcinoma cancer stem cells (MEC), which promotes ferroptosis by inhibiting NRF2 to exert anti-lung cancer efficacy.

HY-152093

YL-939	Inhibitor	99.03%
YL-939 is a potent ferroptosis inhibitor. YL-939 inhibits ferroptosis by targeting the PHB2/ferritin/iron axis.

HY-W009203

L-Cystine dihydrochloride	Inhibitor	≥98.0%
L-Cystine dihydrochloride is the dihydrochloride salt form of L-Cystine (HY-N0394). L-Cystine dihydrochloride elevates Nrf2 protein expression and activates Nrf2 transcription factor. L-cystine dihydrochloride reduces ROS generation and protects against oxidant- or Doxorubicin (HY-15142A)-induced apoptosis. L-Cystine dihydrochloride combined with L-theanine (HY-15121) enhances the production of antigen-specific IgG by increasing glutathione (GSH) levels and T helper 2 (Th2) mediated responses in mice. L-Cystine dihydrochloride is promising for research of cystinuria and kidney stones

HY-112063

CIL56	Activator	99.49%
CIL56 is a potent and selective ferroptosis inducer. Ferroptosis is an iron-dependent form of regulated cell death (RCD).

HY-B0766

Bicyclol		99.91%
Bicyclol (SY801) is an orally active derivative of the traditional Chinese medicine Schisandra chinensis, which has antiviral, anti-inflammatory, immunomodulatory, antioxidant, anti-steatosis, anti-fibrotic and anti-tumor activities. Bicyclol regulates the expression of heat shock proteins and plays an anti-apoptosis role in hepatocytes. Bicyclol reduces the activation of NF-κB and the levels of inflammatory factors in hepatocytes infected with hepatitis C virus (HCV) by inhibiting the activation of the ROS-MAPK-NF-κB pathway, and prevents ferroptosis in acute liver injury. Bicyclol can change the expression of Mdr-1, GSH/GST and Bcl-2, increase the intracellular concentration of anticancer drugs, and sensitize drug-resistant cells to anticancer drugs. Bicyclol inhibits the proliferation of human malignant hepatoma cells by regulating the PI3K/AKT pathway and the Ras/Raf/MEK/ERK pathway. Bicyclol can be used in the study of chronic hepatitis, acute liver injury, nonalcoholic fatty liver disease, liver fibrosis and hepatocellular carcinoma.

HY-153629

FSEN1	Inducer	99.56%
FSEN1 is a potent and non-competitive FSP1 inhibitor with an IC₅₀ value of 313 nM. FSEN1 triggers iron death in cancer cells by inhibiting FSP1. FSEN1 can be used in research of cancer.

Ferroptosis Compound Library

Compound library targeting ferroptosis signaling pathways.

1,293compounds HY-L051

Cystine NOX1 DPP4 Glutamine Tf Methionine Homocysteine p53 CBS Cystathionine Cystine CTH GCLC ABCA1 SREBP2 G6PD γ-glutamylcysteine GSS Ac-CoA HMG-CoA HMGCR Mevalonate Isopentenyl-PP Farnesyl-PP Squalene Squalene-2,3-epoxide Cholesterol FDFT1 SQLE AIFM2 NADPH GSH CDKN1A Se GPX4 Se p21 p53 NRF2 KEAP1 p62 CoQ10 PRDX CHMP5 AKR1Cs CHMP6 ESCRT-Ⅲ Lipid ROS PRDX PRDX GLS2 Glutamine VDAC2/3 GOT1 αKG Fumarate Succinate OXPHOS Citrate Malate ROS ACL Ac-CoA NCOA4 Ferritinophagy Iron Import FTH1 FTL Storage Endosome STEAPs ACACA RAB7A FASN Mal-CoA Fatty Acid Lipophagy Lible iron pool Ferritinophagy STEAP3 NCOA4 Ferritin LDs Storage AA/AdA Ferroptocide TXN PRDX ROS ACSL4 AA/AdA-CoA LPCAT3 AA/AdA-PE TPD52 CAV1 TXN POR ALOXs HMOX1 Heme Fenton
reaction ROS PEX10 PEX3 PUFA-plasmalogen Peroxisome Lysosome CTSB DNA damage/H3 cleavage Membrane oxidative damage Ferroptosis RNS p53 BAP1

Download Ferroptosis Signaling Pathway Map.

Name
Email *

	Sorry, but the email address you supplied was invalid.

Ferroptosis

Ferroptosis

Ferroptosis Related Products (496)

Antibodies (6)

Related Compound Screening Libraries (1)

Ferroptosis Signaling Pathway

Ferroptosis Related Products (496):